ZSEPS Pharmaceuticals: A Ray of Hope for Side-Effect-Free Healing

Vadodara, (Gujarat) [India], May 13: Driven by a personal loss and a deep-seated desire to help others, Aarti Soni, founder of ZSEPS Pharmaceuticals (Zero Side Effect Pain Solution), embarked on a remarkable mission. After witnessing the devastating side effects of conventional pain medication on her brother, Soni, armed with a bachelor’s degree in Home Science and two decades of diverse professional experience, set out to find a better solution.

Fueled by her passion and fueled by over 150 Ayurveda Granth books, Soni poured years of research and development into creating a revolutionary line of medications. In 2024, alongside Chetan Soni and a team of dedicated doctors, ZSEPS Pharmaceuticals was born.

Unveiling India’s First Side-Effect-Free Alternatives

The core of ZSEPS Pharmaceuticals lies in its commitment to providing alternatives to steroids, painkillers, NSAIDs, anti-depressants, and anti-inflammatory pills. Aarti Soni and Chetan Soni have crafted specialised herbo-mineral formulations rooted in Ayurvedic wisdom. The formulations are designed to treat various ailments by addressing the root cause, making ZSEPS Pharmaceuticals a revolution in the healthcare industry.

Aarti Soni’s Vision:

Aarti Soni’s dedication and passion have driven the development of medications effective for a range of conditions, including rheumatoid arthritis, cancer inflammation, tuberculosis, poor gut health, insomnia, attention disorders, anxiety and depression, and skin allergies. The formulations consider individual Prakruti (body type) for a personalised approach to treatment, ensuring maximum effectiveness.

A Mission to Curb Iatrogenic Effects:

The launch of ZSEPS Pharmaceuticals marks a significant step towards reducing iatrogenic effects in healthcare. The company aims to contribute to a healthier society by providing side-effect-free alternatives. The formulations focus on symptomatic relief and delve into the core causes of diseases, promoting internal healing and overall well-being.

The company’s self-manufacturing process ensures precision in every formulation, considering nutritional and therapeutic values. The result is a comprehensive range of medications offering curable treatment without side effects.

“We believe in offering a solution that alleviates symptoms and addresses the root cause of diseases. Our commitment to zero side effects is not just a business strategy; it’s a personal mission born out of pain and loss. We want to provide individuals with a holistic and side-effect-free approach to healthcare,” says Aarti Soni, the visionary founder of ZSEPS Pharmaceuticals.

Focused on internal healing and personalised treatment, ZSEPS Pharmaceuticals is ready to influence the healthcare industry significantly, presenting a blueprint toward a healthier and side-effect-free future for all. The company proves the formidable combination of innovation and compassion, offering millions a hopeful prospect for effective and gentle solutions to their health concerns. ZSEPS Pharmaceuticals charts a course towards a more promising future in pain management, where genuine healing and well-being become accessible to everyone.

If you have any objection to this press release content, kindly contact pr.error.rectification@gmail.com to notify us. We will respond and rectify the situation in the next 24 hours.

Business

KLM Axiva Finvest to Raise Up to Rs 15,000 Lakhs via NCDs

Kochi (Kerala) [India], July 20: KLM Axiva Finvest Ltd has announced the Company’s tenth public issue of secured redeemable non-convertible debentures with a face value of ₹Rs.1000. The base public issue size is ₹7,500 lakhs and the public issue limit will be with an option to retain over-subscription up to ₹7,500 lakhs, aggregating up to […]

Read More
Business

Asian Granito Showcased Latest Tile, Marble, Quartz, and Bathware Collections at IIID Insider X Exhibition Hyderabad

Hyderabad (Telangana) [India], July 20: Asian Granito India Limited (AGL), a leading brand in luxury surface products such as Tiles, Marbles, Quartz, and Bathware solutions proudly presented its latest collections at the IIID Insider X Exhibition held from June 28 to 30, 2024, at the Hitex Exhibition Centre, Hyderabad. This prestigious event, known for its […]

Read More
Business

Aprameya Engineering IPO To Open On 25th July, Sets Price Band at Rs 56 to Rs 58 Per Share

Ahmedabad (Gujarat) [India] July 20 : Incorporated in September 2003, Aprameya Engineering Limited is engaged in Healthcare Infrastructure & supply of need based high value medical equipment like installation, set up & maintenance of Intensive Care Units (ICU), Neonatal Intensive Care Units (NICU), Pediatric Intensive Care Units (PICU), Operation Theatres, and prefabricated structure wards in […]

Read More